| For: | Tsianos EV, Katsanos KH, Tsianos VE. Role of genetics in the diagnosis and prognosis of Crohn's disease. World J Gastroenterol 2012; 18(2): 105-118 [PMID: 22253516 DOI: 10.3748/wjg.v18.i2.105] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i2/105.htm |
| Number | Citing Articles |
| 1 |
Faizan Alawi. An Update on Granulomatous Diseases of the Oral Tissues. Dental Clinics of North America 2013; 57(4) doi: 10.1016/j.cden.2013.07.004
|
| 2 |
Irene Fung, Jackie P.-D. Garrett, Anupama Shahane, Mildred Kwan. Do Bugs Control Our Fate? The Influence of the Microbiome on Autoimmunity. Current Allergy and Asthma Reports 2012; 12(6) doi: 10.1007/s11882-012-0291-2
|
| 3 |
Marianne R. Spalinger, Silvia Lang, Achim Weber, Pascal Frei, Michael Fried, Gerhard Rogler, Michael Scharl. Loss of Protein Tyrosine Phosphatase Nonreceptor Type 22 Regulates Interferon-γ–Induced Signaling in Human Monocytes. Gastroenterology 2013; 144(5) doi: 10.1053/j.gastro.2013.01.048
|
| 4 |
Beatrice E Torere, Henry O Aiwuyo, Jennifer L Kennard. Leukocytoclastic Vasculitis and Myositis as Initial Manifestations of Crohn’s Disease. Cureus 2022; doi: 10.7759/cureus.33127
|
| 5 |
Dipanwita Kapoor, Kathy Teahon, Suzanne VF Wallace. Inflammatory bowel disease in pregnancy. The Obstetrician & Gynaecologist 2016; 18(3) doi: 10.1111/tog.12271
|
| 6 |
Pedro Gonçalves, Fernando Magro, Fátima Martel. Metabolic Inflammation in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2015; 21(2) doi: 10.1097/MIB.0000000000000209
|
| 7 |
Ria Margiana, Hamzah H. Kzar, Fadhil Hussam, Noora M. Hameed, Zahraa Haleem Al-qaim, Moaed E. Al-Gazally, Mahmoud Kandee, Marwan Mahmood Saleh, Bobur Bakhrom ugli Toshbekov, Farkhod Tursunbaev, Sajad Karampoor, Rasoul Mirzaei. Exploring the impact of miR-128 in inflammatory diseases: A comprehensive study on autoimmune diseases. Pathology - Research and Practice 2023; 248 doi: 10.1016/j.prp.2023.154705
|
| 8 |
Raquel Franco Leal, Marciane Milanski, Cláudio Saddy Rodrigues Coy, Mariana Portovedo, Viviane Soares Rodrigues, Andressa Coope, Maria de Lourdes Setsuko Ayrizono, João José Fagundes, Lício Augusto Velloso. Autophagy and proinflammatory cytokine expression in the intestinal mucosa and mesenteric fat tissue of patients with Crohn's disease. Journal of Coloproctology 2013; 33(01) doi: 10.1016/j.jcol.2012.10.001
|
| 9 |
Aysegul Sagir Kahraman. Editorial for “Novel Associations Between Genome‐Wide Single Nucleotide Polymorphisms and MR Enterograpy Features in Crohn's Disease Patients”. Journal of Magnetic Resonance Imaging 2021; 53(1) doi: 10.1002/jmri.27356
|
| 10 |
Xiaolei Wang, Li Qin, Jingli Cao, Jing Zhao. Impact of NOD2/CARD15 polymorphisms on response to monoclonal antibody therapy in Crohn’s disease: a systematic review and meta-analysis. Current Medical Research and Opinion 2016; 32(12) doi: 10.1080/03007995.2016.1226168
|
| 11 |
Mohamad Abbass, Jeremy Cepek, Claire E Parker, Tran M Nguyen, John K MacDonald, Brian G Feagan, Reena Khanna, Vipul Jairath. Adalimumab for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews 2019; 2019(11) doi: 10.1002/14651858.CD012878.pub2
|
| 12 |
Yael Baharad, Tal Engel, Shomron Ben-Horin. Dietary therapy for small bowel Crohn's disease. Current Opinion in Gastroenterology 2026; 42(3) doi: 10.1097/MOG.0000000000001156
|
| 13 |
Liping Guan, Hankui Liu, Ningjing Zhao, Hairui Sun, Lijian Zhao, Jianguo Zhang, Qing Shu. Polygenic risk scores for Crohn’s disease risk prediction in a Chinese population: insights from multi-ethnic genome-wide association studies. European Journal of Medical Research 2026; 31(1) doi: 10.1186/s40001-026-03838-7
|
| 14 |
Matthew A. Croxen, Robyn J. Law, Roland Scholz, Kristie M. Keeney, Marta Wlodarska, B. Brett Finlay. Recent Advances in Understanding Enteric Pathogenic Escherichia coli. Clinical Microbiology Reviews 2013; 26(4) doi: 10.1128/CMR.00022-13
|
| 15 |
Payal Kaw, Yajnadatta Sarangi, Ashok Kumar. Gene, genetics and genetic medicines in gastroenterology: Current status and its future. World Journal of Gastroenterology 2026; 32(1): 112496 doi: 10.3748/wjg.v32.i1.112496
|
| 16 |
Yongchun Shen, Shujin Guo, Ting Yang, Liuqun Jia, Lei Chen, Jing An, Tao Wang, Fuqiang Wen. The -173 G/C Polymorphism of the MIF Gene and Inflammatory Bowel Disease Risk: A Meta-Analysis. International Journal of Molecular Sciences 2013; 14(6) doi: 10.3390/ijms140611392
|
| 17 |
Mingwei Zhang, Tian Qiu, Wenbing Yang, Zhipeng Zhang, Bokai Shi. Bi-omics prognostic model for invasive ductal carcinoma using deep learning. Proceedings of the 2023 4th International Symposium on Artificial Intelligence for Medicine Science 2023; doi: 10.1145/3644116.3644229
|
| 18 |
Mladen Maksic, Irfan Corovic, Tijana Maksic, Jelena Zivic, Milos Zivic, Natasa Zdravkovic, Aleksa Begovic, Marija Medovic, Djordje Kralj, Zeljko Todorovic, Milica Cekerevac, Rasa Medovic, Milos Nikolic. Molecular Insight into the Role of HLA Genotypes in Immunogenicity and Secondary Refractoriness to Anti-TNF Therapy in IBD Patients. International Journal of Molecular Sciences 2025; 26(15) doi: 10.3390/ijms26157274
|
| 19 |
Raquel F. Leal, Francesca A. Ramos Silva. Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging. 2017; doi: 10.1016/B978-0-12-812146-7.00014-7
|
| 20 |
Cinthia Cruz‐Romero, Abra Guo, William F. Bradley, Joao R.T. Vicentini, Vijay Yajnik, Michael S. Gee. Novel Associations Between Genome‐Wide Single Nucleotide Polymorphisms and MR Enterography Features in Crohn's Disease Patients. Journal of Magnetic Resonance Imaging 2021; 53(1) doi: 10.1002/jmri.27250
|
| 21 |
Sanjay Kumar Singh, Atifa Hafeez, Manish Kumar Gupta. Genome Analysis. 2026; doi: 10.1016/B978-0-443-21980-1.00003-6
|
| 22 |
Eiichi Momotani, Hiroshi Ozaki, Masatoshi Hori, Shizuo Yamamoto, Takashi Kuribayashi, Shigetoshi Eda, Masahiro Ikegami. Mycobacterium avium subsp. paratuberculosis lipophilic antigen causes Crohn’s disease-type necrotizing colitis in Mice. SpringerPlus 2012; 1(1) doi: 10.1186/2193-1801-1-47
|
| 23 |
Ketil Størdal, Svend Andersen, Karl Mårild, Vilhelm Larsson, Henrik Imberg. Systematic review and meta-analysis of childhood exposure to antibiotics and the subsequent risk of IBD. Inflammatory Bowel Diseases 2026; 32(5) doi: 10.1093/ibd/izaf324
|
| 24 |
Anna Monica Bianco, Valentina Zanin, Lorenzo Monasta, Stefano Martelossi, Annalisa Marcuzzi, Sergio Crovella. Family history in early-onset inflammatory bowel disease. Journal of Gastroenterology 2013; 48(1) doi: 10.1007/s00535-012-0654-4
|
| 25 |
Plamen K. Krastev, Alexander B. Blazhev, Galya Ts. Stavreva. Effect of Aminosteroid U74389G in a Model of Inflammatory Bowel Disease in Rats. Journal of Biomedical and Clinical Research 2021; 14(2) doi: 10.2478/jbcr-2021-0018
|
| 26 |
Ji-Xiang Zhang, Jia Song, Jun Wang, Wei-Guo Dong. JAK2 rs10758669 Polymorphisms and Susceptibility to Ulcerative Colitis and Crohn's Disease: A Meta-analysis. Inflammation 2014; 37(3) doi: 10.1007/s10753-013-9798-5
|
| 27 |
Tao Jiang, Beibei Qin, Jianqin He, Shuangyan Lin, Shiping Ding. Three isoforms of the Atg16L1 protein contribute different autophagic properties. Molecular and Cellular Biochemistry 2013; 378(1-2) doi: 10.1007/s11010-013-1616-8
|
| 28 |
Yu Wen Li, Ci Qiu Yang, Ying Lian Xiao, Jie Li, Chen Xi Xie, Sheng Hong Zhang, Qiao Yu, Hui Ling Wang, Wei Ming Lu, Min Hu Chen. The ‐A2518G polymorphism in the MCP‐1 gene and inflammatory bowel disease risk: A meta‐analysis. Journal of Digestive Diseases 2015; 16(4) doi: 10.1111/1751-2980.12232
|
| 29 |
Taylor Carter, Van Hoang, Muneera R. Kapadia. Management of Abdominal Crohn's Disease. Surgical Clinics of North America 2026; 106(1) doi: 10.1016/j.suc.2025.08.008
|
| 30 |
Vahab Alamdari-Palangi, Farzaneh Vahedi, Zahra Shabaninejad, Sadat Dokeneheifard, Ahmad Movehedpour, Mortaza Taheri-Anganeh, Amir Savardashtaki. microRNA in inflammatory bowel disease at a glance. European Journal of Gastroenterology & Hepatology 2021; 32(2) doi: 10.1097/MEG.0000000000001815
|
| 31 |
Mario García-Domínguez. Enkephalins and Pain Modulation: Mechanisms of Action and Therapeutic Perspectives. Biomolecules 2024; 14(8) doi: 10.3390/biom14080926
|
| 32 |
Iván Igaz, Mihály Szőnyi, Patrícia Varga, Lajos Topa. Potential relevance of microRNAs in the diagnostics of inflammatory bowel diseases. Orvosi Hetilap 2014; 155(13) doi: 10.1556/OH.2014.29864
|
| 33 |
Erica Chang, Caroline Chinchilla Putzeys, Edward Hoffenberg, Ashish Patel, Elizabeth Hilow, Brad Pasternak. Genital Crohn's disease in pediatrics and genetic associations. JPGN Reports 2025; 6(3) doi: 10.1002/jpr3.70022
|
| 34 |
Mohammad Salem, Jakob Benedict Seidelin, Gerhard Rogler, Ole Haagen Nielsen. Muramyl dipeptide responsive pathways in Crohn’s disease: from NOD2 and beyond. Cellular and Molecular Life Sciences 2013; 70(18) doi: 10.1007/s00018-012-1246-4
|
| 35 |
Anna Duda-Madej, Jakub Stecko, Natalia Szymańska, Agnieszka Miętkiewicz, Marta Szandruk-Bender. Amyloid, Crohn’s disease, and Alzheimer’s disease - are they linked?. Frontiers in Cellular and Infection Microbiology 2024; 14 doi: 10.3389/fcimb.2024.1393809
|
| 36 |
Alexandra-Eleftheria Menni, Georgios Tzikos, George Petrakis, Patroklos Goulas, Panagiotis V. Karathanasis, Stylianos Apostolidis. Comparative Risk of Complications Following Intestinal Surgery After Infliximab, Vedolizumab, or Ustekinumab Treatment: Systematic Review & Meta-Analysis. Pharmaceuticals 2025; 18(10) doi: 10.3390/ph18101466
|
| 37 |
Jin Soo Moon. Clinical Aspects and Treatments for Pediatric Inflammatory Bowel Diseases. Pediatric Gastroenterology, Hepatology & Nutrition 2019; 22(1) doi: 10.5223/pghn.2019.22.1.50
|
| 38 |
ManzoorA Malik. MDR1C3435T polymorphism and inflammatory bowel disease. Saudi Journal of Gastroenterology 2015; 21(2) doi: 10.4103/1319-3767.153843
|
| 39 |
Ludwig J. Horst, Jan Kempski, Martine Walmsley, Samuel Huber, Christoph Schramm. PSC and colitis: A complex relationship. Hepatology 2025; 82(4) doi: 10.1097/HEP.0000000000001236
|
| 40 |
Jixiang Zhang, Jianhong Wu, Xiulan Peng, Jia Song, Jun Wang, Weiguo Dong, Georgina L. Hold. Associations between STAT3 rs744166 Polymorphisms and Susceptibility to Ulcerative Colitis and Crohn's Disease: A Meta-Analysis. PLoS ONE 2014; 9(10) doi: 10.1371/journal.pone.0109625
|
| 41 |
Sanjana Vijay Nemade, Kiran Jaywant Shinde. Granulomatous diseases in Otorhinolaryngology, Head and Neck. 2021; doi: 10.1007/978-981-16-4047-6_23
|
| 42 |
Sanja Dragasevic, Biljana Stankovic, Tomica Milosavljevic, Aleksandra Sokic-Milutinovic, Snezana Lukic, Tamara Alempijevic, Branka Zukic, Nikola Kotur, Gordana Nikcevic, Sonja Pavlovic, Dragan Popovic. Genetic and environmental factors significant for the presentation and development of inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 2017; 29(8) doi: 10.1097/MEG.0000000000000877
|
| 43 |
Mohamad Abbass, Jeremy Cepek, Claire E Parker, Tran M Nguyen, John K MacDonald, Brian G Feagan, Reena Khanna, Vipul Jairath. Adalimumab for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews 2017; doi: 10.1002/14651858.CD012878
|
| 44 |
Naif Alenazi, Hesham Alsaeed, Adel Alsulami, Turki Alanzi. A Review of Hyperbaric Oxygen Therapy for Inflammatory Bowel Disease. International Journal of General Medicine 2021; doi: 10.2147/IJGM.S336678
|
| 45 |
Bruno Lorenzo SCOLARO, Emily dos SANTOS, Leslie Ecker FERREIRA, Paulo Henrique Condeixa de FRANÇA, Harry KLEINUBING, Paulo Gustavo KOTZE, Mauro de Souza Leite PINHO. T300A GENETIC POLYMORPHISM: a susceptibility factor for Crohn’s disease?. Arquivos de Gastroenterologia 2014; 51(2) doi: 10.1590/S0004-28032014000200005
|
| 46 |
|
| 47 |
|
| 48 |
Diana Lacruz-Guzmán, Daniel Torres-Moreno, Francisco Pedrero, Patricia Romero-Cara, Iván García-Tercero, Javier Trujillo-Santos, Pablo Conesa-Zamora. Influence of polymorphisms and TNF and IL1β serum concentration on the infliximab response in Crohn’s disease and ulcerative colitis. European Journal of Clinical Pharmacology 2013; 69(3) doi: 10.1007/s00228-012-1389-0
|
| 49 |
Gary R Lichtenstein, Edward V Loftus, Kim L Isaacs, Miguel D Regueiro, Lauren B Gerson, Bruce E Sands. ACG Clinical Guideline: Management of Crohn's Disease in Adults. American Journal of Gastroenterology 2018; 113(4) doi: 10.1038/ajg.2018.27
|
| 50 |
Jin Soo Moon. Clinical aspects and treatments for pediatric inflammatory bowel disease. Intestinal Research 2019; 17(1) doi: 10.5217/ir.2018.00139
|
| 51 |
Ivana Kern, Olaf Schoffer, Thomas Richter, Wieland Kiess, Gunter Flemming, Ulf Winkler, Jürgen Quietzsch, Olaf Wenzel, Marlen Zurek, Ulf Manuwald, Janice Hegewald, Shi Li, Jens Weidner, Jan de Laffolie, Klaus-Peter Zimmer, Joachim Kugler, Martin W. Laass, Ulrike Rothe, Mathilde Body-Malapel. Current and projected incidence trends of pediatric-onset inflammatory bowel disease in Germany based on the Saxon Pediatric IBD Registry 2000–2014 –a 15-year evaluation of trends. PLOS ONE 2022; 17(9) doi: 10.1371/journal.pone.0274117
|
| 52 |
Seana ML Nelson, Tran M Nguyen, John WD McDonald, John K MacDonald. Natalizumab for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews 2018; 2018(8) doi: 10.1002/14651858.CD006097.pub3
|